These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32864894)

  • 1. Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice.
    Wu F; Sun H; Gong W; Li X; Pan Z; Shan H; Zhang Z
    CNS Neurosci Ther; 2021 Feb; 27(2):220-232. PubMed ID: 32864894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREK-1 Null Impairs Neuronal Excitability, Synaptic Plasticity, and Cognitive Function.
    Wang W; Kiyoshi CM; Du Y; Taylor AT; Sheehan ER; Wu X; Zhou M
    Mol Neurobiol; 2020 Mar; 57(3):1332-1346. PubMed ID: 31728930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
    Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
    PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREK1 channel blockade induces an antidepressant-like response synergizing with 5-HT1A receptor signaling.
    Ye D; Li Y; Zhang X; Guo F; Geng L; Zhang Q; Zhang Z
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2426-36. PubMed ID: 26441141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Two-Pore Domain Potassium Channel TREK-1 Inhibits the Activation of A1-Like Reactive Astrocyte Through the NF-κB Signaling Pathway in a Rat Model of Major Depressive Disorder.
    Cong T; Sun Y; Zhou Y; Wu H; Li L; Chu Z; Chen X; Li J; Zhao D; Wang Y; Liu Y; Yin S; Xiao Z
    Neurochem Res; 2023 Jun; 48(6):1737-1754. PubMed ID: 36670238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Knockdown of TREK-1 in Hippocampal Neurons Attenuate Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.
    Kim A; Jung HG; Kim YE; Kim SC; Park JY; Lee SG; Hwang EM
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swimming exercise reverses CUMS-induced changes in depression-like behaviors and hippocampal plasticity-related proteins.
    Liu W; Xue X; Xia J; Liu J; Qi Z
    J Affect Disord; 2018 Feb; 227():126-135. PubMed ID: 29055260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TREK-1: a potential target for novel antidepressants].
    Maruyama Y; Yamada M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Aug; 27(4):147-51. PubMed ID: 17879592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mild stress alters synaptic plasticity in the nucleus accumbens through GSK3β-dependent modulation of Kv4.2 channels.
    Aceto G; Colussi C; Leone L; Fusco S; Rinaudo M; Scala F; Green TA; Laezza F; D'Ascenzo M; Grassi C
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8143-8153. PubMed ID: 32209671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MST1 in hippocampus protects against stress-induced depression-like behaviours and synaptic plasticity impairments.
    Yan Y; Xu X; Chen R; Wu S; Yang Z; Wang H; Zhang T
    Brain Behav Immun; 2021 May; 94():196-209. PubMed ID: 33607238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides.
    Pietri M; Djillani A; Mazella J; Borsotto M; Heurteaux C
    Neuropharmacology; 2019 Nov; 158():107715. PubMed ID: 31325429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression.
    Lin DH; Zhang XR; Ye DQ; Xi GJ; Hui JJ; Liu SS; Li LJ; Zhang ZJ
    CNS Neurosci Ther; 2015 Jun; 21(6):504-12. PubMed ID: 25675906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Therapeutic Effects of TREK1 Blockers and Fluoxetine on Chronic Unpredicted Mild Stress Sensitive Rats.
    Qi X; Xu H; Wang L; Zhang Z
    ACS Chem Neurosci; 2018 Nov; 9(11):2824-2831. PubMed ID: 29952548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator.
    Joseph A; Thuy TTT; Thanh LT; Okada M
    PLoS One; 2018; 13(8):e0201092. PubMed ID: 30110354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cold temperature on cellular excitability of hippocampal networks.
    de la Peña E; Mälkiä A; Vara H; Caires R; Ballesta JJ; Belmonte C; Viana F
    PLoS One; 2012; 7(12):e52475. PubMed ID: 23300680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression.
    Qiao H; An SC; Xu C; Ma XM
    Brain Res; 2017 May; 1663():29-37. PubMed ID: 28284898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF improves CUMS-induced depressive behaviors through downregulating Ras/ERK/MAPK signaling pathway.
    Li H; Linjuan-Li ; Wang Y
    Biochem Biophys Res Commun; 2016 Oct; 479(4):827-832. PubMed ID: 27680311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in lipid-sensitive two-pore domain potassium channel TREK-1 expression and its involvement in astrogliosis following cerebral ischemia in rats.
    Wang M; Song J; Xiao W; Yang L; Yuan J; Wang W; Yu Z; Xie M
    J Mol Neurosci; 2012 Feb; 46(2):384-92. PubMed ID: 21789545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
    Tsai SJ
    Med Hypotheses; 2008; 70(3):548-50. PubMed ID: 17703894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.
    Borsotto M; Veyssiere J; Moha Ou Maati H; Devader C; Mazella J; Heurteaux C
    Br J Pharmacol; 2015 Feb; 172(3):771-84. PubMed ID: 25263033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.